What are you looking for? Write the name, title or any keyword related to what you are looking for and select which content category it belongs to. Search Fulltext search Activities Professionals Research groups News - Any - News VHIR leads European project for the early treatment of blindness due to diabetes Diabetes and metabolism group at Vall d'Hebron Institut de Recerca (VHIR), led by Dr. Rafael Simó, will coordinate a European consortium to investigate early treatment of diabetic retinopathy (EUROCONDOR), the leading cause of blindness among people of working age in developed countries. The project News VHIR recognized as an example of biomedical foundation In a report on foundations and biomedical research published on April 29 in La Vanguardia, Arantxa Tobaruela, partner at Garrigues, says Vall d'Hebron Research Institute Foundation (VHIR) is an example of good practice in the process of professionalization to stay as an international reference in bi News Vall d'Hebron and Parc Tauli will collaborate on the development of innovation projects Vall d’Hebron University Hospital (HUVH), Vall d'Hebron Research Institute (VHIR), Parc Taulí Health Corporation (CSPT) and Parc Tauli Foundation (FPT) have signed a framework agreement establishing a partnership in the models and processes of innovation and transfer, as well as scientific and techn News Aún hay margen para la mejora de las ecuaciones de riesgo cardiovascular "Aún hay margen para la mejora de las ecuaciones para calcular el riesgo cardiovascular", según otro ponente de la Primera Jornada de Investigación del Instituto Catalán de la Salud, Rafael Ramos, del Instituto de Investigación en Atención Primaria (Idiap) Jordi Gol.Diario Medico. Patricia Morén. Ba News El gen KLF12 se asocia a más riesgo de artritis reumatoide La medicina y la sanidad avanzan gracias a buenas ideas. Algunas deslumbran por su espectacularidad, por su origen o por su impacto mediático, pero es la suma de todas, también de las que a veces pasan más inadvertidas, lo que hace que el progreso biomédico dé pasos en la mejora de la calidad de vid News Joan Xavier Comella serà el nou director de l’Institut de Recerca de l’HUVH Doctor en medicina i cirurgia i amb una àmplia trajectòria centrada en l’àmbit de la investigació bàsica en neurociències, Joan Xavier Comella dirigia fins ara la Fundació Catalana per a la Investigació i Innovació (FCRI). News L’Institut de Recerca Hospital Universitari Vall d’Hebron ha estat acreditat per l’Instituto de Salud Carlos III com a Institut d’Investigació Sanitària. El passat mes de novembre, l’Institut de Recerca Hospital Universitari Vall d’Hebron (IR-HUVH) ha estat acreditat per l’Instituto de Salud Carlos III com a Institut d’Investigació Sanitària, d’acord amb el què estableix el RD339/2004 i l’ordre que el regula, l’Ordre 1245/2006 sobre acreditació d’I News El tubo de plata previene la neumonía en ventilados en UCI El tubo endotraqueal recubierto de plata es útil en la prevención de la neumonía en pacientes con ventilación mecánica y las evidencias obtenidas en distintos estudios avalan la extensión del uso de este dispositivo, según el investigador Jordi Rello, de Tarragona.Diario Medico. Patricia Morén. Barc News Los biobancos son cruciales para buscar marcadores en EA La búsqueda de marcadores tempranos de la enfermedad de Alzheimer es esencial para diagnosticarla y tratarla precozmente. Un recurso que puede contribuir mucho a esta investigación es disponer de más muestras de tejidos nerviosos en biobancos, según Isidre Ferrer.Diario Medico. Patricia Morén. Barce News Suport a projectes de recerca d’investigadors de l’HUVH finançats per La Marató Suport a projectes de recerca d’investigadors de l’HUVH finançats per La Marató de TV3 2007 La Fundació la Marató de TV3 ha concedit ajuts a projectes de recerca biomèdica d’excel·lència sobre les malalties cardiovasculars a dos especialistes de l’HUVH: els doctors Jaume Casaldàliga, coordinador de News Una nueva cirugía de la espina bífida evita suturar al feto Una cirugía consistente en cerrar la malformación debida a la espina bífida, con un parche y un sellante quirúrgico, evita suturar al feto, con los riesgos que entraña esta parte del procedimiento, y reduce el tiempo quirúrgico, según el primer caso hecho en el Valle de Hebrón.Diario Medico. Patrici News Julia Winter, new CEO of Transbiomed, VHIR’s spin-off Julia Winter is the new CEO of Transbiomed, the spin-off of the Vall d'Hebron, Institut de Recerca (VHIR) that has recently developed a urine test for early diagnosis of prostate cancer. Born in Colorado (USA), Winter has accumulated nearly 20 years experience in the field of scientific and business News VHIR and Fenexy cooperate in the healing of spinal injuries Vall d'Hebron Institut de Recerca (VHIR) and Fenexy Foundation, aiming to cure spinal cord injuries, have signed an agreement for which VHIR will be part of the Scientific Committee of Fenexy, represented by its director, Dr. Joan Comella. On April 14, a delegation of Fenexy visited VHIR and spinal News Gut Bacteria Divide People Into 3 Types This global classification allows researchers to define, in their search, the number of variables that may be implicated in disease, moving closer correlation between the state of the intestinal flora and the health of the individual. News The Catalan government honours Dr. Simon Schwartz Riera with the ‘Creu de Sant Jordi’ Dr. Simon Schwartz Riera, who created the Vall d'Hebron Foundation for Research in 1994 and former responsible for the CIBBIM-Nanomedicine at Vall d’Hebron Research Institute (VHIR), has been honoured with the ‘Creu de Sant Jordi’, the maximum honor by the Government of the Generalitat of Catalunya. News New VHIR institutional video Introducing the "http://www.youtube.com/user/VHIRtv#p/a/f/0/vlFDQx95k6Y" new video of Vall d'Hebron Research Institute (VHIR). It is a story of who we are, what we want to be and how we want to be seen. Thank you all for your cooperation. "http://www.youtube.com/user/VHIRtv#p/a/f/0/vlFDQx95k6Y" V News VHIR's research shows it's possible to use gene therapy for MNGIE disease Researchers from Vall d'Hebron Research Institute (VHIR) have discovered a possible treatment for patients with the life-threatening minority disease MNGIE. The research group on neuromuscular and mitochondrial diseases, in collaboration with the gene therapy group at VHIR have been able, thanks to News VHIR will collaborate with COMB to support innovative projects of its researchers Vall d'Hebron Institute for Research (VHIR) and the Official College of doctors of Barcelona (COMB) have signed an agreement under which COMB will offer services of technological innovation, analysis and support of entrepreneurial activities to VHIR's researchers. As a result of VHIR intention of be News Dr. Alijotas participates in the program on sterility of '36,5' at BTV Dr. Jaume Alijotas, head of the research in Pregnancy immunopathology at Vall d'Hebron Research Institute (VHIR), participates with his patient during the show '36,5' of BTV, which in its latest edition has been dedicated to infertility. During the program, presented by Dr. Eduard Estivill, there ar News A new generation of drugs improves treatment of hepatitis C Two-thirds of patients with the most common form of hepatitis C can be cured with a new generation of antiviral drugs, as publishes in The New England Journal of Medicine a group of researchers in which appears Dr. Rafael Esteban Mur, member of the liver diseases group at Vall d'Hebron Institute of Pagination First page « Previous page ‹ … Page 146 Page 147 Current page 148 Page 149 Page 150 … Next page › Last page »
